|
|
||||||||
Department of Cardiovascular Surgery, German Heart Center Munich, Munich, Germany
Accepted for publication January 20, 2009.
* Address correspondence to Dr Krane, German Heart Center Munich, Department of Cardiovascular Surgery, Lazarettstr 36, Munich, 80636, Germany (Email: krane{at}dhm.mhn.de).
| Abstract |
|---|
|
|
|---|
Methods: We studied 71 patients (41 male) with a mean age of 83 ± 2.8 years, who underwent cardiac reoperation between 1994 and 2006. These patients were compared with 71 octogenarians who underwent primary cardiac operation. Patients were matched for age, sex, year of operation, and surgical procedure. Demographic profiles, operative data, long-term survival, and quality of life by the Short-Form 36-Item Health Survey questionnaire were analyzed.
Results: Average time between previous operation and reoperation was 10.8 ± 5.6 years (range: 1.7 to 30.6). The 30-day mortality rate was 14.7% in the reoperation group and 8.5% (p = 0.43) in the control group. Actuarial survival at 1, 3, and 6 years was 71% ± 5.5%, 60.5% ± 6.1%, and 30% ± 8.1% for patients who underwent cardiac reoperation; and 77.2% ± 5%, 58.3% ± 6.3%, and 36.3% ± 7.8% for matched octogenarians who underwent primary cardiac surgery (p = 0.68). No significant differences were found between groups regarding the physical health summarized score (40.7 ± 9.4 versus 39.1 ± 10; p = 0.55) and the mental health summarized score (51.9 ± 10.9 versus 48 ± 12.9; p = 0.24) of the Short-Form 36-Item Health Survey questionnaire.
Conclusions: Octogenarians exhibit a similar long-term survival and quality of life after primary and redo cardiac surgery. Therefore, cardiac reoperation should not be a contraindication per se in octogenarians.
| Introduction |
|---|
|
|
|---|
Different studies reported higher rates for operative mortality and postoperative complications in octogenarians [5, 6] undergoing primary cardiac surgery. Alexander and colleagues [7] reported a significantly increased in-hospital mortality for coronary artery bypass graft surgery (CABG) [8.1% versus 3%]) and aortic valve replacement (AVR) plus CABG (10.1% versus 7.9%) among 4,743 octogenarians compared with younger patients (both p < 0.05). In their study, incidences of postoperative complications like renal failure, neurologic events, and perioperative myocardial infarction were also significantly increased among patients aged 80 years and older compared with younger patients (p < 0.05).
Only a few studies have investigated the outcome of octogenarians undergoing cardiac reoperation. These studies reported varying results (for example, an early mortality rate between 5.5% and 32%) or included only small patient numbers [8–11]. Because of a lack of information regarding reoperations in octogenarians, we analyzed our experience for postoperative outcome and long-term survival after reoperation. Furthermore, the current status of quality of life (QoL) was assessed using the standardized Short-Form 36-Item Health Survey Questionnaire (SF-36).
| Material and Methods |
|---|
|
|
|---|
Short-Form 36 Health Survey Questionnaire
The SF-36 was used to evaluate the quality of life in the study and control group. The test is validated for different age groups, especially for elderly patients [12]. The SF-36 consists of 36 items grouped in eight general health categories: physical functioning, role-physical, role-emotional, social functioning, mental health, bodily pain, vitality, and general health. The number of possible responses per item varies from 2 to 6. The eight categories could be grouped into two summarized scores: the physical health score (physical functioning, role-physical, bodily pain, and general health) and the mental health score (role-emotional, social functioning, mental health, and vitality). For each category, scores are calculated and transformed to a scale from 0 to 100, with higher scores reflecting a better quality of life. The questionnaire evaluates the status of quality of life for the last 4 weeks. The SF-36 questionnaire was sent by mail to the survivors of both groups.
Statistical Analysis
Results are presented as mean ± 1 SD. Dichotomous variables are given as percentage. For comparisons of dichotomous variables, Fisher's exact test was used. The t test was used to compare continuous variables. Actuarial survival was calculated with the Kaplan-Meier method. Comparisons between groups were made by the log-rank test. To evaluate results of the SF-36, the t test for comparisons by means was used. Results of the SF-36 were presented as mean ± 1 SE. All statistical analyses were performed using SPSS 15 software (SPSS, Chicago, IL).
| Results |
|---|
|
|
|---|
|
|
|
|
|
|
| Comment |
|---|
|
|
|---|
Postoperative Morbidity
Craver and colleagues [5] found a significantly increased rate for the requirement of an IABP in 601 octogenarians (3.7%) compared with younger patients (aged 70 to 79 years, 2.1%; aged 60 to 69 years, 1.5%). Gosh and colleagues [10] described, in 18 octogenarians who underwent cardiac reoperation, an incidence of 16.6% for the postoperative use of an IABP. These reported incidences for the use of an IABP in octogenarians for primary cardiac operation and cardiac reoperation are similar to our findings. Odell and colleagues [15] reported, in 145 patients with a mean age of 71 years who underwent AVR after previous CABG, a high incidence of 18.6% for the use of an IABP. In conclusion, octogenarians showed a higher incidence for hemodynamic instabilities requiring an IABP compared with younger patients. Octogenarians who underwent cardiac reoperation showed a higher rate for the use of an IABP compared with octogenarians who underwent primary cardiac surgery.
Eitz and associates [9] reported a significantly increased rate for rethoracotomy among 71 octogenarians who underwent redo AVR (11.3%) compared with primary AVR (1.4%). We found a comparable rethoracotomy rate of 9.9% among octogenarians who underwent cardiac reoperation.
Thirty-Day Mortality and Long-Term Survival
In our study population, the 30-day mortality rate among patients undergoing primary cardiac operation was 8.5%, and for cardiac reoperations it was 14.1%. The difference of the 30-day mortality rate was not statistically significant (p = 0.43), probably caused by the small patient number in our study population. Table 4
summarizes the operative mortality rate given as 30-day or hospital mortality rate of previously published studies on reoperation procedures in octogenarians [8–11]. The overall calculated operative mortality rate was 13.84% (31 of 224), comparable to our 30-day mortality rate of 14.1%.
|
Results of studies comparing the early mortality rate among patients younger than 80 years between primary and cardiac reoperation are controversial. Sundt and colleagues [3] found no difference for the 30-day mortality rate among patients who underwent AVR with or without CABG as reoperation procedure (7.7%) compared with patients who underwent primary AVR plus CABG (6.3%) [3]. They concluded that the risk of AVR after previous CABG is similar to that for primary AVR plus CABG. In contrast, Salomon and coworkers [17] found a significantly increased operative mortality rate among patients younger than 80 years who underwent CABG as reoperation procedure (6.9%) as compared with patients who had CABG as their primary operation (2%).
Owing to the high operative mortality rate among octogenarians—in particular, among octogenarians who underwent cardiac reoperation—special emphasis has to be placed on surgical treatment options to improve the surgical outcome. During the last years, new transapical or percutaneous transarterial approaches for AVR were developed. Walther and colleagues [18] reported a study of 59 patients who underwent transapical AVR (aged more than 75 years) with a European System for Cardiac Operative Risk Evaluation (EuroSCORE) predicted risk for mortality of 27%. In their study, the actual 30-day mortality was 13.6% even for these high-risk patients. Grube and colleagues [19] reported a series of 86 patients (aged more than 75 years) undergoing percutaneous transarterial AVR with a 30-day mortality of 12%. In their study, the predicted EuroSCORE for mortality was 21%.
We were not able to identify preoperative risk factors for the early mortality among octogenarians who underwent cardiac reoperation because of an insufficient statistical power due to a limited patient number. For preoperative patient selection, different studies found reduced ejection fraction, previous myocardial infarction, preoperative renal insufficiency, urgent or emergency surgery, and chronic obstructive lung disease as independent predictors for the in-hospital mortality of octogenarians who underwent primary cardiac surgery [7, 13, 16, 20, 21]. He and colleagues [22] described emergency status (p = 0.0001), reduced ejection fraction (p = 0.0002), sex (p = 0.011), and history of arrhythmia (p = 0.023) as independent preoperative variables for the operative mortality in patients younger than 80 years who underwent cardiac reoperation.
Eitz and colleagues [9] reported that for 71 octogenarians with AVR reoperation, long-term survival at 1 year and at 3 and 5 years was 76.1%, 70.8%, and 57%, respectively, compared with 87.3%, 70.4%, and 51.3%, respectively, for octogenarians who underwent primary AVR. The difference for actuarial survival was not statistically significant (p = 0.646). These findings are similar to our results regarding differences in long-term survival between octogenarians who underwent primary surgery and cardiac reoperation.
In summary, cardiac surgery for octogenarians is related to a higher 30-day mortality rate compared with younger patients. Cardiac reoperation is probably associated with a higher operative mortality compared with primary cardiac surgery. There are no established independent risk factors for operative mortality of octogenarians undergoing cardiac reoperation. Therefore, established independent risk factors for operative mortality of octogenarians who underwent primary cardiac surgery and established independent risk factors for patients who underwent cardiac reoperation have to be taken into account for patient selection. Transapical or transcatheter AVR were possible surgical treatment options to improve the high operative mortality rate of octogenarians who need aortic valve replacement as a reoperation procedure.
Quality of Life
In addition to survival, the evaluation of the postoperative quality of life provides more complete information about the outcome after cardiac surgery. We used the SF-36 to evaluate the QoL. The retrospective study design did not allow the comparison of QoL between preoperative and postoperative status, so it cannot be concluded whether the scores reflect an improvement in QoL.
Blanche and colleagues [8] reported that, among octogenarians who underwent cardiac reoperation, 80% to 90% of the survivors had an improvement and a satisfying functional status after cardiac reoperation, whereas 5% to 15% noted no real changes after cardiac reoperation. The data were evaluated by a formal and validated QoL questionnaire. Fruitman and colleagues [23] also used the SF-36 for evaluation of the QoL in 103 octogenarians who underwent cardiac surgery. They described for role-physical and role-emotional significantly increased scores for octogenarians compared with a general population. Tseng and coworkers [24] reported their results with 70 of 159 survivors aged between 70 and 89 years who underwent aortic valve replacement. Their study population scored better for seven of eight categories compared with a general population. For the mental health score alone, their study population showed a clearly decreased score compared with the standard population aged 75 years and older of the SF-36. Both studies also used the SF-36 to evaluate the QoL after cardiac surgery procedures in a retrospective study design.
Quality of life of octogenarians undergoing primary cardiac surgery is comparable to an age-related general population. Quality of life for octogenarians undergoing cardiac reoperation is similar to that for octogenarians undergoing primary cardiac surgery. For the evaluation of an improvement in QoL after cardiac surgery, further prospective trials with a preoperative and postoperative comparison are necessary.
In conclusion, cardiac reoperation for octogenarians showed a high early mortality. Therefore, the decision for cardiac reoperation has to be carefully made with respect to established independent risk factors for octogenarians undergoing primary cardiac surgery and established risk factors for cardiac reoperation. Primary cardiac surgery and cardiac reoperation for octogenarians showed a similar long-term survival and QoL. Therefore, cardiac reoperation should not be a contraindication per se for patients aged 80 years and older, and this kind of surgery should not be reserved for younger patients alone.
| References |
|---|
|
|
|---|
Related Article
This article has been cited by other articles:
![]() |
M. Krane, B. Voss, A. Hiebinger, M. A. Deutsch, M. Wottke, A. Hapfelmeier, C. C. Badiu, R. Bauernschmitt, and R. Lange Twenty Years of Cardiac Surgery in Patients Aged 80 Years and Older: Risks and Benefits Ann. Thorac. Surg., February 1, 2011; 91(2): 506 - 513. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Rizzoli, J. Bejko, T. Bottio, V. Tarzia, and G. Gerosa Valve surgery in octogenarians: does it prolong life? Eur J Cardiothorac Surg, May 1, 2010; 37(5): 1047 - 1055. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. E. MacGillivray Invited Commentary Ann. Thorac. Surg., May 1, 2009; 87(5): 1385 - 1385. [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |